3:首次持股聲明-高管 JONES WILLIAM A JR
05/03 16:22 (美東)
PRE 14A:並購重組委托聲明
04/29 17:06 (美東)
424B3:募資說明書
04/19 16:25 (美東)
EFFECT:其他
04/18 06:06 (美東)
NewAmsterdam Pharma | POS AM:修改註冊聲明表
04/12 16:20 (美東)
NewAmsterdam Pharma | 4:持股變動聲明-高管 Audet Juliette Berangere
04/02 16:37 (美東)
NewAmsterdam Pharma | 8-K:重大事件
04/01 08:21 (美東)
NewAmsterdam Pharma | 4:持股變動聲明-董事 Topper James N
03/28 16:36 (美東)
NewAmsterdam Pharma | 4:持股變動聲明-高管 Kastelein Johannes Jacob Pieter
03/27 16:36 (美東)
NewAmsterdam Pharma | 144:擬議出售證券
03/26 17:40 (美東)
NewAmsterdam Pharma | 424B3:募資說明書
03/12 16:26 (美東)
NewAmsterdam Pharma | EFFECT:其他
03/11 06:06 (美東)
NewAmsterdam Pharma | 8-K:重大事件
03/04 08:10 (美東)
NewAmsterdam Pharma | SC 13D/A:超過5%持股股東披露文件(修正)-BCLS Fund III Investments, LP(6.0%),BCLS II Investco, LP(5.4%)等
03/01 16:37 (美東)
NewAmsterdam Pharma | POS AM:修改註冊聲明表
02/28 17:19 (美東)
NewAmsterdam Pharma | 8-K:重大事件
02/28 08:12 (美東)
NewAmsterdam Pharma | 10-K:年度報表
02/28 08:02 (美東)
NewAmsterdam Pharma | 4:持股變動聲明-董事 LANGE LOUIS G
02/21 17:08 (美東)
NewAmsterdam Pharma | SC 13D/A:超過5%持股股東披露文件(修正)-James N. Topper(14.2%),Patrick J. Heron(14.2%)等
02/21 11:15 (美東)
NewAmsterdam Pharma | 8-K:重大事件
02/15 16:25 (美東)
暫無數據
暫無數據